0001012975-16-001221.txt : 20160513
0001012975-16-001221.hdr.sgml : 20160513
20160513140734
ACCESSION NUMBER: 0001012975-16-001221
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20160331
FILED AS OF DATE: 20160513
DATE AS OF CHANGE: 20160513
EFFECTIVENESS DATE: 20160513
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Flagship Ventures Fund IV, L.P.
CENTRAL INDEX KEY: 0001503559
IRS NUMBER: 364678982
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-17451
FILM NUMBER: 161647523
BUSINESS ADDRESS:
STREET 1: ONE MEMORIAL DRIVE
STREET 2: 7TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-868-1888
MAIL ADDRESS:
STREET 1: ONE MEMORIAL DRIVE
STREET 2: 7TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001503559
XXXXXXXX
03-31-2016
03-31-2016
Flagship Ventures Fund IV, L.P.
ONE MEMORIAL DRIVE
7TH FLOOR
CAMBRIDGE
MA
02142
13F HOLDINGS REPORT
028-17451
N
Noubar B. Afeyan, Ph.D
Manager
617-868-1888
/s/ Noubar B. Afeyan, Ph.D
Cambridge
MA
05-13-2016
0
3
381843
false
INFORMATION TABLE
2
Flagship_IV.xml
Eleven Biotherapeutics, Inc.
COM
286221106
469
1466417
SH
SOLE
1466417
0
0
Seres Therapeutics Inc
COM
81750R102
374060
14083579
SH
SOLE
14083579
0
0
T2 Biosystems, Inc.
COM
89853L104
7314
741755
SH
SOLE
741755
0
0